¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Small Ubiquitin-Related Modifier Proteins"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® serum proteins ÇÑ±Û Ç÷û´Ü¹é
¼³¸í   
  Ç÷û¿¡ Àִ ´Ü¹éÁúµéÀ» ÃÑĪÇϴ ¸»·Î, ¸é¿ª±Û·ÎºÒ¸°(¸é¿ªÇö»ó¿¡ °ü¿©Çϴ Ç×ü¸¦ Çü¼ºÇÔ), ¾ËºÎ¹Î, º¸Ã¼ ¹× ÀÀ°íÀÎÀÚ¿Í ¿©·¯ È¿¼ÒµéÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù.
¿µ¹® small intestine ÇÑ±Û ÀÛÀºÃ¢ÀÚ, ¼ÒÀå
¼³¸í   
  À§¿Í Å«Ã¢ÀÚ »çÀÌÀÇ ±æÀÌ 5m³»¿ÜÀÇ ¼ÒÈ­±â°üÀ¸·Î¼­ »ùâÀÚ, ºóâÀÚ, µ¹Ã¢ÀÚÀÇ ¼¼ ºÎºÐÀ¸·Î ±¸¼ºµÊ.
  
  1)»ùâÀÚ: ¼ÒÀåÀÇ Á¦ÀϠùºÎºÐÀ¸·Î¼­ ±æÀÌ 25cmÀÇ CÀÚÇü¸ð¾ç. »óºÎ, ³»¸², °¡·Î, ¿À¸§ÀÇ ³×ºÎÀ§·Î ±¸¼ºµÇ¸ç, »óºÎ ºÎÀ§¸¦ Á¦¿ÜÇϰí´Â ¸ðµÎ µÚº¹º®¿¡ °íÁ¤µÇ¾î ÀÖÀ¸¸ç ³»ºÎ¿¡´Â µ¹¸²ÁÖ¸§À̶ó´Â Á¡¸· ÁÖ¸§ÀÌ Á¸ÀçÇÔ. À§¿¡¼­ ³Ñ¾î¿Â ¼ÒÈ­µÈ À½½ÄÀÌ ´ãÁó, ÀÌÀھ׿¡¼­ ºÐºñµÇ´Â ¼ÒÈ­È¿¼Ò¾×)°ú ¼¯À̴ Àå¼ÒÀ̸ç Ã¶ÀÌ Èí¼öµÇ´Â Àå¼ÒÀÓ.
  
  2)ºóâÀÚ:ÀÛÀºÃ¢ÀÚÀÇ µÎ¹øÂ° ºÎºÐÀ¸·Î¼­ ±ÙÀ§ºÎ 2/5¸¦ Â÷ÁöÇÔ. °øÀåÀº È¸Àå¿¡ ºñÇØ Á÷°æÀÌ Å©°í À庮ÀÌ µÎ²¨¿ì¸ç Ç÷°üÀ̠dzºÎÇϰí Àå°£¸·ÀÌ Åõ¸íÇϰí Á÷ÇàÇ÷°üÀÌ ±ä °ÍÀ̠Ư¡ÀÓ.
  
  3)µ¹Ã¢ÀÚ:ÀÛÀºÃ¢ÀÚÀÇ ¸¶Áö¸· ºÎºÐÀ¸·Î¼­ ¿øÀ§ºÎ 3/5À» Â÷ÁöÇÔ. Æ¯È÷ µ¹Ã¢ÀÚ, Å«Ã¢ÀÚ ÀÌÇàºÎ ºÎÀ§¿¡´Â ÆÄÀ̾îÆÇÀ̶ó´Â ¸²ÇÁÀýÀÌ Á¸ÀçÇϸç, À̰÷Àº °¢Á¾ Áúº´ÀÇ Áß¿äÇÑ ¹ß»ý ºÎÀ§°¡ µÊ. ´ãÁó¿° ¹× ºñŸ¹Î B12°¡ Èí¼öµÇ´Â Àå¼ÒÀÓ.
¿µ¹® small bowel series ÇÑ±Û ÀÛÀºÃ¢ÀÚ Á¶¿µ¼ú, ¼ÒÀå Á¶¿µ¼ú
¼³¸í   
  ¹æ»ç¼± Á¶¿µÁ¦(¹æ»ç¼±°Ë»ç¿¡¼­ ´Ù¸¥ ºÎÀ§¿Í ´ëÁ¶µÇ´Â ¾ÆÁÖ Èò»öÀ» ¶ì´Â ¹°Áú)ÀΠ¹Ù·ýÀ» ¼·ÃëÇÑ µÚ, ÃÔ¿µÇϴ ÀÛÀºÃ¢ÀÚÀÇ ±âº»ÀûÀΠ¹æ»ç¼± °Ë»ç·Î¼­, ¹æ¹ýÀº 200~300mLÀÇ ¹Ù·ýÀ» ¸ÔÀºµÚ ¹Ù·ýÀÌ ÀÛÀº Ã¢ÀÚ¸¦ Åë°úÇϴ µ¿¾È Á¤±ÔÀû °£°ÝÀ¸·Î ¹æ»ç¼± »çÁøÀ» ÂïÀ½. ÀϹÝÀûÀ¸·Î 2~3½Ã°£ÀÌ °É¸².
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • biologic response modifier
    »ý¹°ÇÐÀû¹ÝÀÀÁ¶ÀýÁ¦, »ýü¹ÝÀÀÁ¶Àý¹°Áú
  • biological response modifier
    »ý¹°ÇÐÀû¹ÝÀÀÁ¶ÀýÁ¦, »ýü¹ÝÀÀÁ¶Àý¹°Áú
  • modifier
    1. Á¶ÀýÁ¦ 2. º¯°æÀÎÀÚ
  • chronic lymphoblastic leukemia/small lymphocytic lymphoma
    ¸¸¼º¸²ÇÁ¸ð±¸¹éÇ÷º´/¼Ò¸²ÇÁ±¸¸²ÇÁÁ¾
  • non-small cell carcinoma
    ºñ¼Ò¼¼Æ÷¾ÏÁ¾
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
  • small cell lung cancer
    ¼Ò¼¼Æ÷Æó¾Ï, ÀÛÀº¼¼Æ÷ÇãÆÄ¾Ï
  • small for gestational age
    ÀӽųªÀ̺¸´Ù ÀÛÀº ¿µ¾Æ
  • small intestine
    ÀÛÀºÃ¢ÀÚ, ¼ÒÀå
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
  • small intestine
    ÀÛÀºÃ¢ÀÚ, ¼ÒÀå
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • biologic response modifier
    »ýü¹ÝÀÀÁ¶Àý¹°Áú, »ý¹°ÇÐÀû¹ÝÀÀÁ¶ÀýÁ¦
  • modifier
    º¯°æÀÎÀÚ, Á¶ÀýÁ¦
  • molecular weight modifier
    ºÐÀÚ·®Á¶ÀýÁ¦
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
  • small cell lung cancer
    ÀÛÀº¼¼Æ÷ÇãÆÄ¾Ï, ¼Ò¼¼Æ÷Æó¾Ï
  • small intestine
    ÀÛÀºÃ¢ÀÚ, ¼ÒÀå
  • small pox
    µÎâ, õ¿¬µÎ
  • small angle strabismus
    ¹Ì¼¼°¢»ç½Ã
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • artery,small
    ¼Òµ¿¸Æ(á³ÔÑØæ)
  • G-proteins
    G-´Ü¹é(Ó±ÛÜ)
  • g proteins
    G ´Ü¹é
  • g-proteins
    G´Ü¹éÁú
  • guanosine triphosphate(gtp)-bindting proteins
    »ïÀλ걸¾Æ³ë½Å°áÇմܹéÁú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • biologic response modifier, BRM
    »ýü¹ÝÀÀÁ¶Àý¹°Áú
  • biological response modifier (BRM)
    »ý¹°ÇÐÀû¹ÝÀÀÁ¶Àý¹°Áú (BRM)
  • modifier
  • molecular weight modifier
    ºÐÀÚ·®Á¶ÀýÀÚ.
  • g proteins
    G ´Ü¹é
  • g-proteins
    G´Ü¹éÁú
  • glycosyl phosphatidyl inositol-linked proteins
    Glycosyl phosphatidyl inositol-linked proteins
  • guanosine triphosphate(gtp)-bindting proteins
    »ïÀλ걸¾Æ³ë½Å°áÇմܹéÁú
  • stress proteins
    ½ºÆ®·¹½º´Ü¹éÁú(¡­Ó±ÛÜòõ)
  • artery,small
    ¼Òµ¿¸Æ(á³ÔÑØæ)
  • digitate dermatosis => parapsoriasis, small plaque
  • duplication of small intestine
    ¼ÒÀåÀÇ Áߺ¹Áõ(á³ ¡­ñìÜÜñø).
  • immunoprofiferative small intestinal disease
  • intestine, large,small
    ¼ÒÀå(á³íó)
  • mixed small and large cell lymphoma
    È¥ÇÕ¼º ´ë¼Ò¼¼Æ÷ ¸²ÇÁÁ¾(¡­ ÓÞá³á¬øà ¡­ðþ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Openings of small veins
    ¹Ì¼¼Á¤¸Æ±¸¸Û
    [¿¾ ¿ë¾î] ¼ÒÁ¤¸Æ±¸
  • Small saphenous vein
    ÀÛÀºµÎ··Á¤¸Æ
    [¿¾ ¿ë¾î] ¼Òº¹ÀçÁ¤¸Æ
  • Small lymphocyte
    ÀÛÀº¸²ÇÁ±¸
    [¿¾ ¿ë¾î] ¼ÒÀӯı¸
  • Small fusiform neuron
    ÀÛÀº¹æÃß¼¼Æ÷
    [¿¾ ¿ë¾î] ¼Ò¹æÃ߻󼼯÷
  • Small stellate neuron
    ÀÛÀºº°¼¼Æ÷
    [¿¾ ¿ë¾î] ¼Ò¼º»ó¼¼Æ÷
  • Small cell part
    ÀÛÀº¼¼Æ÷ºÎºÐ
    [¿¾ ¿ë¾î] ¼Ò¼¼Æ÷ºÎ
  • Small cardiac vein
    ÀÛÀº½ÉÀåÁ¤¸Æ
    [¿¾ ¿ë¾î] ¼Ò½ÉÀåÁ¤¸Æ
  • SMALL INTESTINE
    ÀÛÀºÃ¢ÀÚ [¼ÒÀå]
    [¿¾ ¿ë¾î] ¼ÒÀå
  • Small pyramidal neuron
    ÀÛÀºÇǶó¹Ô¼¼Æ÷
    [¿¾ ¿ë¾î] ¼ÒÃßü½Å°æ¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • biological response modifier
    »ý¹°ÇÐÀû ´ëÀÀ¼ö½ÄÀÚ(ßæÚªùÊîÜÓßëëáóãÞí­)
  • modifier
    ¼ö½ÄÀÚ(áóãÞí­)
  • small-angle x-ray diffraction
    ¼Ò°¢(á³ÊÇ) X-¼±(àÊ) ȸÀý(üÞï¹)
  • small calorie
    ¼Ò(á³) Ä®·Î¸®
  • small cytoplasmic ribonucleoproteins
    ¼Ò(á³) ¼¼Æ÷Áú(á¬øàòõ) ¶óÀ̺¸ÇÙ»ê´Ü¹éÁú(ú·ß«Ó±ÛÜòõ)
  • small cytoplasmic RNA
    ¼Ò(á³) ¼¼Æ÷Áú(á¬øàòõ)RNA
  • small lymphocyte
    ¼Ò(á³)Àӯı¸
  • small nuclear RNA
    ¼Ò(á³) ÇÙ(ú·)RNA
  • small nuclear ribonucleoprotein
    ¼Ò(á³) ÇÙ(ú·) ¶óÀ̺¸ÇÙ»ê´Ü¹éÁú(ú·ß«Ó±ÛÜòõ)
  • bundling proteins
    ±Ù¼Ó´Ü¹éÁú(ÐÉáÖÓ±ÛÜòõ)
  • capping proteins
    ĸÇü¼º(û¡à÷) ´Ü¹éÁú(Ó±ÛÜòõ)
  • extrinsic proteins
    ¿ÜÀÎ ´Ü¹éÁú (èâì×Ó±ÛÜòõ)
  • high-quality proteins
    °í±Þ ´Ü¹éÁú(ÍÔÐäÓ±ÛÜòõ)
  • integral proteins
    ÅëÇմܹéÁú(÷ÖùêÓ±ÛÜòõ)
  • labile proteins
    ºÒ¾ÈÁ¤´Ü¹éÁú(ÝÕäÌïÒÓ±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • small bowel series
    ¼ÒÀåÁ¶¿µ¼ú
  • small cell
    ¼Ò¼¼Æ÷
  • small cleaved cell
    ¼ÒºÐÇÒ¼¼Æ÷
  • small intestine
    ÀÛÀºÃ¢ÀÚ, ¼ÒÀå
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
BRM biological response modifier; biuret reactive material
PBPs Penicillin-Binding Proteins
PVM pneumonia virus of mice; proteins, vitamins, and minerals
RPSP reference preparation for serum proteins
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BRM Biological Response Modifier
CrmA Cytokine response modifier A
G proteins GIP-binding proteins
G-proteins GTP)-binding regulatory proteins
G-proteins Guanine nucleotide-binding regulatory proteins
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • biologic response modifier
    »ýü ¹ÝÀÀ º¯ÇüÀÚ
  • modifier
    Á¶Á¦Á¦, Á¶ÀýÁ¦, º¯¼ºÁ¦, º¯°æ ÀÎÀÚ, ¼ö½Ä ÀÎÀÚ
    º¯È­½ÃŰ´Â °Í.
  • network modifier
    ¼ö½Ä»êÈ­¹°
    ´Üµ¶À¸·Î´Â ±Û¶ó½º Çü¼º ´É·ÂÀÌ ¾øÁö¸¸, ±Û¶ó½º Çü¼º »êÈ­¹°¿¡ ¹èÇÕÇÒ ¶§, ±Û¶ó½ºÀÇ ¼ºÁúÀ» °³¼±ÇÏ´Â »êÈ­¹°.
  • opaque modifier ºÒÅõ¸íµµÀÇ »öÀ» ¿©·¯ °¡Áö·Î º¯ÇüÇØ ¸¸µç ºÒÅõ¸í¼Ò.

    opaque porcelain

    ºÒÅõ¸í µµÀç
  • duplication of small intestine
    ¼ÒÀåÀÇ Áߺ¹Áõ
  • mixed small and large cell lymphoma
    È¥ÇÕ¼º ´ë¼Ò¼¼Æ÷ ¸²ÇÁÁ¾
  • openings of small vein
    ¹Ì¼¼ Á¤¸Æ ±¸¸Û
  • small atrial septal defect
    ¹Ì¼¼ ½É¹æ Áß°Ý °á¼Õ
  • small bowel series
    ¼ÒÀå Á¶¿µ¼ú
  • small cell
    ¼Ò¼¼Æ÷
  • small cleaved cell
    ¼ÒºÐÇÒ ¼¼Æ÷
  • small intestine
    ÀÛÀº âÀÚ, ¼ÒÀå
    µ¿ÀǾî=intestinum tenue. 1. À§¿Í ´ëÀå »çÀÌ¿¡ ÀÖ´Â ±æÀÌ 6¡­7 m¿¡ À̸£´Â ¼ÒÈ­°ü. À§¾×¿¡ ÀÇÇØ ¾ÏÁ×ó·³ µÈ À½½Ä¹°Àº ¼ÒÀåÀ» Åë°úÇÏ´Â »çÀÌ¿¡ ¼ÒÀ庮¿¡¼­ ºÐºñµÇ´Â Àå¾×, °£¿¡¼­ ¸¸µé¾îÁö´Â ¾µ°³Áó, ÀÌÀÚ¿¡¼­ ³ª¿À´Â ÀÌÀÚ¾× µî°ú È¥ÇյȴÙ. ¼ÒÀåÀº ¼ÒÈ­ ¿îµ¿À» Çϸ鼭 ¿µ¾çºÐÀ» ¼ÒÈ­, Èí¼öÇÏ´Â Áß¿äÇÑ ºÎºÐÀÌ´Ù. ¼ÒÀåÀº À§¿¡¼­ºÎÅÍ ½ÊÀÌÁöÀå, °øÀå, ȸÀåÀÇ ¼¼ ºÎºÐÀ¸·Î ±¸ºÐÇÑ´Ù. °øÀå°ú ȸÀåÀÇ ±æÀÌÀÇ ºñ´Â ¾à 2:3 Á¤µµÀ̸ç, ½ÊÀÌÁöÀåÀº Èĺ¹º®¿¡ ưưÇÏ°Ô °íÁ¤µÇ¾î ÀÖÀ¸³ª, °øÀå°ú ȸÀåÀº º¹°­ ¼Ó¿¡ ±æ°Ô ÆÛÁ®¼­ Àå°£¸·¿¡ ÀÇÇÏ¿© º¹º®¿¡ ¿¬°áµÇ¾î ÀÖ´Ù. ±×·±µ¥´Ù Àå°£¸·ÀÇ ±æÀ̰¡ 15¡­25 cm³ª µÇ¹Ç·Î, °øÀå°ú ȸÀåÀº °¡µ¿¼ºÀÌ Å©´Ù. °øÀå°ú ȸÀåÀ» ÇÕÃļ­ À¯Àå°£¸· ¼ÒÀåÀ̶ó°í ÇÑ´Ù. °øÀåÀº ȸÀ庸´Ù ¾à°£ ±½°í º®ÀÌ µÎ²¨¿ì¸ç, Ç÷°üÀÇ ºÐÆ÷µµ °øÀå¿¡ ¸¹´Ù. ½Ãü¸¦ ÇØºÎÇßÀ» °æ¿ì, °øÀåÀº ³»¿ë¹°ÀÌ ºñ¾î ÀÖ´Â °æ¿ì°¡ ¸¹°í, ȸÀåÀº º¹°­ ¼Ó¿¡¼­ ²ÙºÒ²ÙºÒÇÏ°Ô µÇ¾î Àֱ⠶§¹®¿¡ ÀÌ¿Í °°ÀÌ ¸í¸íµÇ¾ú´Ù. ¼ÒÀå ³»¸éÀÇ Á¡¸·¿¡´Â À±»óÀ¸·Î »¸¾îÀÖ´Â ¼ö¸¹Àº ÁÖ¸§ÀÌ ÀÖ°í, ÁÖ¸§ÀÇ Ç¥¸é¿¡´Â À¶¸ð¶ó°í ÇÏ´Â ±æÀÌ 0.5¡­1 mmµÇ´Â Á¡¸· µ¹±â°¡ »ª»ªÇÏ°Ô µ¸¾Æ ÀÖ´Ù. À¶¸ð »çÀÌ·Î Á¡¸· Á¶Á÷¿¡ µé¾î ÀÖ´Â Àå¼±ÀÌ ¿­·Á ÀÖ¾î Àå¾×À» ÀÌ °÷À¸·Î ºÐºñÇÑ´Ù. À±»óÀÇ ÁÖ¸§Àº ½ÊÀÌÁöÀå°ú °øÀå¿¡´Â ¸¹À¸³ª ȸÀå¿¡´Â Àû´Ù. ¼ÒÀå Á¡¸·¿¡´Â Ư¼öÇÑ ¸²ÇÁ Á¶Á÷ÀÌ ¹ß´ÞÇØ Àִµ¥ À̰Ϳ¡´Â µÎ Á¾·ù°¡ ÀÖ´Ù. Çϳª´Â Á¡¸·¸é¿¡ Áö¸§ 1¡­1.5 mmÀ̰í Èò»öÀ» ¶í µ¹Ã⹰ó·³ º¸ÀÌ´Â °í¸³ ¸²ÇÁ ¼ÒÀý·Î¼­, ÀÌ ¸²ÇÁ ¼ÒÀýÀº Àå Àüü¿¡ ÆÛÁ® ÀÖ´Ù. ´Ù¸¥ Çϳª´Â ÁýÇÕ ¸²ÇÁ ¼ÒÀý·Î À̰ÍÀº °í¸³ ¸²ÇÁ ¼ÒÀýÀÌ ¹ÐÁýÇÑ °ÍÀ¸·Î, Áö¸§ 2¡­10 cmÀÎ ±äÀå Ÿ¿øÇüÀ» ÀÌ·ç°í ÀÖÀ¸¸ç ¼ÒÀýÀÇ ÀåÃàÀº ÀåÀÇ ±äÃà ¹æÇâ°ú ÀÏÄ¡Çϰí Àִµ¥, ±× ¼ö´Â ¾à 15¡­30°³ Á¤µµÀÌ´Ù. Àå °áÇÙÀ̳ª ÀåÆ¼Çª½º µî¿¡ °É¸®¸é ÀÌ ºÎºÐ¿¡¼­ ±Ë¾çÀÌ »ý±ä´Ù. ¼ÒÀåÀÇ ±â´É¿¡´Â ¿îµ¿ ±â´É, ºÐºñ ±â´É, Èí¼ö ±â´ÉÀÇ ¼¼ °¡Áö°¡ ÀÖ´Ù. 2. À¯¹® ¾Æ·¡¿¡¼­ ¸ÍÀå Àü¿¡ À̸£´Â 5-6m ±æÀÌÀÇ ¼ÒÈ­°üÀ¸·Î ½ÊÀÌÁöÀå, °øÀå, ȸÀåÀÇ 3ºÎºÐÀ¸·Î ±¸¼ºµÇ¾î ÀÖ°í, ¼ÒÈ­µÈ ¿µ¾çºÐÀ» Èí¼ö Ç÷·ù³ª ¸²ÇÁ°üÀ¸·Î ¿î¹ÝÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù.
  • small lymphocyte
    ÀÛÀº ¸²ÇÁ±¸, ¼Ò¸²ÇÁ±¸
  • small patent ductus arteriosus
    ¹Ì¼¼ µ¿¸Æ°ü °³Á¸
  • small pox
    µÎâ, õ¿¬µÎ
    1. µÎâ ¹ÙÀÌ·¯½º¿¡ ÀÇÇϳª, ÀÌ ¹ÙÀÌ·¯½º´Â ȯÀÚÀÇ ºñÀεΠºÐºñ¾×, ³óÆ÷, Ç÷¾× Áß¿¡ ÀÖÀ¸¸ç, °ÇÁ¶¿¡ °­ÇÏ°í ¸ÕÁö ¼Ó¿¡¼­µµ ¸î °³¿ù¾¿ »ýÁ¸ÇÏ°í °¨¿°·ÂÀÌ °­ÇÏ´Ù. ±â¹°, °ø±â¸¦ ÅëÇÏ¿©¼­µµ Àü¿°ÇÑ´Ù. µ¿³²¾Æ½Ã¾Æ¿¡ µÎâ »óÀçÁö°¡ ÀÖ´Ù. Àẹ±â´Â 11-14ÀÏ, Á¾µÎ¸¦ ¹ÞÀº ºÒ¿ÏÀü ¸é¿ª »óÅ¿¡¼­´Â 3ÁÖ°£ Á¤µµ ¿¬ÀåÇÑ´Ù. ¸é¿ªÀÌ ÀüÇô ¾ø´Â °æ¿ì¿¡ ÁøµÎÀÇ Áõ»óÀ» ³ªÅ¸³»°í ºÒ¿ÏÀüÇÑ ¸é¿ª »óÅÂÀÇ °æ¿ì¿¡´Â °æÁõÀÇ °¡µÎÀÇ Áõ»óÀ» ³ªÅ¸³½´Ù. ÇÕº´ÁõÀº ¼¼±Õ¿¡ ÀÇÇÑ 2Â÷ °¨¿°ÀÌ ¸¹´Ù. Ä¡·á´Â ´ëÁõÀûÀ¸·Î ¿¹¹æÀº Á¾µÎ ȯÀÚÀÇ Á¶±â ¿ÏÀü °Ý¸®ÀÌ´Ù. 2. Æø½º ¹ÙÀÌ·¯½º°ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
biological response modifier <pharmacology, oncology> A substance used in adjuvant therapy that takes advantage of the bodys own natural defense mechanisms to inhibit the growth of a tumour.
(16 Dec 1997)
modifier gene A nonallelic gene that controls or changes the manifestation of a gene by interfering with its transcription.
(05 Mar 2000)
effect modifier A factor that modifies the effect of a putative causal factor under study; e.g., age is an effect modifier for many conditions.
(05 Mar 2000)
bilaterally small, smooth kidneys <radiology> Generalised atherosclerosis, nephrosclerosis - benign and malignant, atheroembolic renal disease, chronic glomerulonephritis, papillary necrosis, hereditary diseases, hereditary chronic nephritis (Alport's syndrome), medullary cystic disease, amyloidosis (late), arterial hypotension Cf: other urographic patterns
(12 Dec 1998)
carcinoma, non-small-cell lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. They are dealt with collectively because of the shared properties of poor response to conventional chemotherapy and the potential for cure with surgical resection in a fraction of patients.
(12 Dec 1998)
carcinoma, small cell An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterised by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. There are admixtures of small cell lung carcinoma with other types of lung cancer. Small cell carcinomas are distinguished by their distinctive biological features, response to chemotherapy and radiotherapy, and by their nearly universal tendency to develop overt or subclinical metastases, which frequently eliminates surgery in most patients.
(12 Dec 1998)
generalised small bowel disease <radiology> Hypoproteinaemia, sprue, Whipple
(12 Dec 1998)
mesenteric portion of small intestine The freely movable portion of the small intestine supplied with a mesentery, comprising the jejunum and ileum.
Synonym: mesenteric portion of small intestine.
(05 Mar 2000)
ribonucleoproteins, small nuclear Highly conserved nuclear RNA-protein complexes that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3'-end processing in the nucleoplasm. The u3 snrnp is localised in the nucleolus, where it aligns into base pairs with the 28s rrna precursor in a still unidentified region and functions in pre-rrna processing. The u7 snrnp aligns into base pairs with a conserved sequence in the 3'-end of histone pre-mRNA and is an essential cofactor for the cleavage that creates the mature nonadenylated 3'-end.
(12 Dec 1998)
ribonucleoproteins, small, u1 A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the u1 snrnp along with other small ribonucleoproteins (u2, u4-u6, and u5) assemble into spliceosomes that remove introns from pre-mRNA by splicing. The u1 snrnp base pairs with conserved sequence motifs at the 5'-splice site and recognises both the 5'- and 3'-splice sites and may have a fundamental role in aligning the two sites for the splicing reaction.
(12 Dec 1998)
ribonucleoproteins, small, u2 A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the u2 snrnp along with other small ribonucleoproteins (u1, u4-u6, and u5) assemble into spliceosomes that remove introns from pre-mRNA by splicing. The u2 snrnp base pairs with conserved sequence motifs at the branch point, which associates with a heat- and rnaase-sensitive factor in an early step of splicing.
(12 Dec 1998)
ribonucleoproteins, small, u4-u6 A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the u4-u6 snrnp along with the u5 snrnp preassemble into a single 25s particle that binds to the u1 and u2 snrnps and the substrate to form mature spliceosomes. There is also evidence for the existence of individual u4 or u6 snrnps in addition to their organization as a u4-u6 snrnp.
(12 Dec 1998)
ribonucleoproteins, small, u5 A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the u5 snrnp along with u4-u6 snrnp preassemble into a single 25s particle that binds to the u1 and u2 snrnps and the substrate to form mature spliceosomes.
(12 Dec 1998)
RNA, small nuclear Short chains of RNA found in the nucleus. Their function is to remove the introns (nontranslated intervening sequences) from mRNA precursors, thereby bringing the two exons (coding segments) together into correct juxtaposition for enzymatic splicing at the correct point. The resulting mRNA is now ready to leave the nucleus.
(12 Dec 1998)
mucosa of small intestine The mucous coat of the small intestine.
Synonym: tunica mucosa intestini tenuis.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Small Ubiquitin-Related Modifier Proteins - »õâ A class of structurally related proteins of 12-20 kDa in size. They covalently modify specific proteins in a manner analogous to UBIQUITIN.
    Synonyms : Sentrin Proteins, Sentrins, Ubiquitin-Related Modifier Protein, Small, Small Ubiquitin Related Modifier Proteins, Ubiquitin Related Modifier Protein, Small
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • modifier
    ¼öÁ¤ÀÚ;¼ö½Ä¾î
  • small
    ÀÛÀº,ÀÛÀººÎºÐ,ÀÛÀº ¼Ò¸®·Î
  • small
    ÀÛÀº;Á¼Àº;(¼öÀÔ µûÀ§)ÀûÀº;½Ã½ÃÇÑ;ÇÏÂúÀº;ÀλöÇÑ (a man of ~ mind ¼ÒÀÎ);and ~ wonder;...À̶ó°í ÇØ¼­ ³î¶ö °ÍÀº ¸ø µÈ´Ù;feel ~ ¶¸¶¸Ä¡¸øÇϰÔ(ºÎ²ô·´°Ô)¿©±â´Ù;look~ Ç®ÀÌ Á×´Ù;ÀÛ°Ô;ÀÛÀº (¸ñ)¼Ò¸®
  • small arms
    ÈÞ´ë¿ë ¹«±â
  • small beer
    ¾àÇÑ ¸ÆÁÖ;ÇÏÂúÀº °Í
  • small capital
    ¼ÒÇü ´ë¹®ÀÚ
  • small change
    Àܵ·;½Ã½ÃÇÑ À̾߱â
  • small fry
    ¾î¸°¾Öµé;ÀÛÀº µ¿¹°;½Ã½ÃÇÑ Ä£±¸µé;ÀÛÀº µ¿¹°;µ¿¹°ÀÇ »õ³¢;ÀÛÀº ¹°°í±â
  • small holder
    ¼Ò ÀÚÀÛ³ó
  • small holding
    ¼ÒÀÚÀÛ ³óÁö
  • small hours
    ÇѹãÁß(1,2,3½Ã°æ)
  • small potatoes
    ½Ã½ÃÇÑ °Í
  • small rain
    ºÎ½½ºñ;À̽½ºñ !
  • small talk
    ÇÑ´ã;¼¼»ó À̾߱â
  • small time
    (ÇÏ·ç¿¡ ¸î¹ø¾¿ »ó¿¬ÇÏ´Â)½Î±¸·Á ¿¬¿¹(¿¬±Ø)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á